Shree Ganesh Remedies Limited (BOM:540737)
India · Delayed Price · Currency is INR 506.40
+4.75 (0.95%)
At close: Aug 21, 2026
Shree Ganesh Remedies Revenue
Shree Ganesh Remedies had revenue of 152.99M INR in the quarter ending June 30, 2026, a decrease of -37.98%. This brings the company's revenue in the last twelve months to 992.55M, down -8.51% year-over-year. In the fiscal year ending March 31, 2026, Shree Ganesh Remedies had annual revenue of 1.09B with 0.63% growth.
Revenue (ttm)
992.55M
Revenue Growth
-8.51%
P/S Ratio
6.57
Revenue / Employee
6.64M
Employees
149
Market Cap
6.50B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.09B | 6.89M | 0.63% |
| Mar 31, 2025 | 1.09B | -172.99M | -13.74% |
| Mar 31, 2024 | 1.26B | 356.76M | 39.54% |
| Mar 31, 2023 | 902.20M | 189.32M | 26.56% |
| Mar 31, 2022 | 712.88M | 222.06M | 45.24% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bajaj HealthCare | 6.28B |
| NGL Fine-Chem | 5.36B |
| Sai Parenteral's | 5.26B |
| Aarey Drugs & Pharmaceuticals | 4.15B |
| Anlon Healthcare | 2.26B |
| Influx Healthtech | 1.47B |
| Smruthi Organics | 1.12B |
| Panchsheel Organics | 1.08B |
Shree Ganesh Remedies News
- 1 year ago - Shree Ganesh Remedies shares tumble over 8% after Q4 net profit drops 48% YoY - Business Upturn
- 1 year ago - Shree Ganesh Remedies commissions 2.5 MW solar power project, expects Rs 2 crore annual savings - Business Upturn